Telemedicine for Children With Sickle Cell Disease

Indiana University

Status: Enrolling

Conditions: Anemia, Sickle Cell

Treatments: Other: Types of Telemedicine Delivery Models

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05087303

1K23HL143162-01A1 (U.S. NIH Grant/Contract)

2101344406

Details and patient eligibility

About

The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consumer) for use with children with SCD using caregiver input from our preliminary K12 work. Aim 2: Demonstrate the feasibility of the telemedicine models developed in Aim 1 as the models undergo successive stakeholder refinement during use in actual clinical care. Aim 3: Evaluate the effectiveness of the refined models from Aim 2 in a pre/post study by assessing (a) process of care measures, (b) provider satisfaction, (c) caregiver/patient-centered outcomes, and (d) clinical outcomes and healthcare utilization.

Enrollment: 60 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Caregivers must be 18 years or older, who have children between 0 to 21 years old with a diagnosis of Sickle Cell Disease and receive care at the Riley Hospital for Children Comprehensive Sickle Cell Disease clinic.
• Adolescent patients 16 years and older are also able to participate in interviews/surveys.
• The family must be willing to receive their care using the telemedicine model available to them based on the location of their primary residence.
• TeleSCD model participants must live within 1 hour of the pre-identified telemedicine sites, while VirtualSCD model participants must live within the city limits of the pre-identified area.

Exclusion criteria

• If a patient receives chronic transfusion therapy, they will not be eligible to participate, as our telemedicine models will not support this.

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Hub and Spoke

Active Comparator group

Treatment:

Other: Types of Telemedicine Delivery Models

Direct to Consumer

Active Comparator group

Treatment:

Other: Types of Telemedicine Delivery Models